首页 > 最新文献

Cureus最新文献

英文 中文
Parathyroid Carcinoma Complicated by Parathyromatosis and Refractory Hypercalcemia. 甲状旁腺癌并发甲状旁腺色素沉着症和难治性高钙血症
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-28 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72584
Yug Garg, Madhumati S Vaishnav, Nidhi Garg, Kavitha Muniraj, Sathyanarayana Srikanta

Parathyroid carcinoma (PC) is a rare malignancy. In January 2022, a 41-year-old woman presented with weight loss, proximal muscle weakness, and bone pain. She was diagnosed with severe hypercalcemia with serum calcium of 15.5 mg/dL (8.8-10.6 mg/dL). A biopsy of cervical lymphadenopathy revealed non-caseating granulomatous lymphadenitis. Primary hyperparathyroidism was subsequently confirmed with parathormone (PTH) exceeding 2,500 pg/mL (12-88 pg/mL), leading to left-superior parathyroidectomy and hemithyroidectomy. Histopathology suggested PC versus adenoma, with oxyphilic cells. Postoperatively, she manifested severe hypocalcemia and vitamin D deficiency alongside elevated PTH levels. In January 2023, she experienced a hypercalcemic crisis and developed a new right-sided neck mass. Wide excision revealed PC with parathyromatosis. By September 2023, another hypercalcemic crisis and new left cervical nodules necessitated further surgery, confirming PC deposits in the neck, though without lymph node metastases. Despite treatment with cinacalcet and zoledronic acid, her hypercalcemia persisted until denosumab produced a dramatic response (serum calcium dropping from 16.7 to 7.9 mg/dL; PTH 1,168 pg/mL). However, she remains at risk for progressive local disease and potential distant metastases.

甲状旁腺癌(PC)是一种罕见的恶性肿瘤。2022 年 1 月,一名 41 岁女性因体重减轻、近端肌肉无力和骨痛前来就诊。她被诊断为严重高钙血症,血清钙为 15.5 mg/dL(8.8-10.6 mg/dL)。颈部淋巴结活检显示为非酪氨酸肉芽肿性淋巴结炎。随后确诊为原发性甲状旁腺功能亢进,副甲状腺激素(PTH)超过2,500 pg/mL(12-88 pg/mL),因此进行了左上方甲状旁腺切除术和半甲状腺切除术。组织病理学检查结果表明,她患有嗜氧细胞的PC腺瘤。术后,她表现出严重的低钙血症和维生素 D 缺乏,同时 PTH 水平升高。2023 年 1 月,她经历了一次高钙血症危象,并出现了新的右侧颈部肿块。广泛切除后发现 PC 伴有甲状旁腺瘤病。到 2023 年 9 月,她再次出现高钙血症危象,并出现新的左侧颈部结节,因此有必要进一步手术治疗,手术证实她的颈部有 PC 沉积,但没有淋巴结转移。尽管接受了西那卡西特和唑来膦酸治疗,但她的高钙血症仍持续存在,直到地诺单抗产生了显著反应(血清钙从 16.7 毫克/分升降至 7.9 毫克/分升;PTH 1,168 pg/mL)。然而,她仍然面临着局部疾病进展和潜在远处转移的风险。
{"title":"Parathyroid Carcinoma Complicated by Parathyromatosis and Refractory Hypercalcemia.","authors":"Yug Garg, Madhumati S Vaishnav, Nidhi Garg, Kavitha Muniraj, Sathyanarayana Srikanta","doi":"10.7759/cureus.72584","DOIUrl":"10.7759/cureus.72584","url":null,"abstract":"<p><p>Parathyroid carcinoma (PC) is a rare malignancy. In January 2022, a 41-year-old woman presented with weight loss, proximal muscle weakness, and bone pain. She was diagnosed with severe hypercalcemia with serum calcium of 15.5 mg/dL (8.8-10.6 mg/dL). A biopsy of cervical lymphadenopathy revealed non-caseating granulomatous lymphadenitis. Primary hyperparathyroidism was subsequently confirmed with parathormone (PTH) exceeding 2,500 pg/mL (12-88 pg/mL), leading to left-superior parathyroidectomy and hemithyroidectomy. Histopathology suggested PC versus adenoma, with oxyphilic cells. Postoperatively, she manifested severe hypocalcemia and vitamin D deficiency alongside elevated PTH levels. In January 2023, she experienced a hypercalcemic crisis and developed a new right-sided neck mass. Wide excision revealed PC with parathyromatosis. By September 2023, another hypercalcemic crisis and new left cervical nodules necessitated further surgery, confirming PC deposits in the neck, though without lymph node metastases. Despite treatment with cinacalcet and zoledronic acid, her hypercalcemia persisted until denosumab produced a dramatic response (serum calcium dropping from 16.7 to 7.9 mg/dL; PTH 1,168 pg/mL). However, she remains at risk for progressive local disease and potential distant metastases.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11524608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Risk Factors for Post-operative Complications in Laparoscopic Common Bile Duct Exploration: A Literature Review. 探索腹腔镜胆总管探查术后并发症的风险因素:文献综述。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-28 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72570
Mina Manasseh, Islam Mt Elsamalouty, Cho Nu San, Marcos Kostalas

Gallstone-related diseases, particularly common bile duct (CBD) stones, pose a significant global health challenge. The emergence of laparoscopic common bile duct exploration (LCBDE) has transformed the management of these conditions by offering a less invasive alternative to traditional open surgery. This literature review aims to analyze published literature to identify and understand the risk factors associated with LCBDE. The study aims to offer valuable insights that could potentially enhance patient care and outcomes in managing CBD stones. A comprehensive search of English-language studies from the past 20 years was conducted using PubMed, focusing on peer-reviewed primary research, systematic reviews, and meta-analyses. From 830 initial articles, 25 were selected based on relevance and availability. The review identified several key risk factors influencing LCBDE outcomes, including patient-related factors such as advanced age, high comorbidity scores, narrow bile ducts, and complex stones, which increase the likelihood of complications. Surgeon experience also plays a crucial role, with lower complication rates observed among surgeons who have performed at least 70 LCBDE procedures over a 10-year period. Additionally, procedure-related factors such as the transcystic (TC) approach, primary suture (PS) closure, and intraoperative imaging were found to reduce complication rates. LCBDE remains a promising approach for managing bile duct stones, particularly when patient, surgeon, and procedural factors are optimized.

胆石相关疾病,尤其是胆总管(CBD)结石,对全球健康构成了重大挑战。腹腔镜胆总管探查术(LCBDE)的出现改变了这些疾病的治疗方法,为传统开腹手术提供了一种创伤较小的替代方案。本文献综述旨在分析已发表的文献,以确定并了解与腹腔镜胆总管探查术相关的风险因素。该研究旨在提供有价值的见解,从而有可能在CBD结石的治疗过程中加强对患者的护理并提高治疗效果。我们使用 PubMed 对过去 20 年的英文研究进行了全面搜索,重点关注同行评审的主要研究、系统综述和荟萃分析。根据相关性和可用性,从 830 篇初始文章中筛选出 25 篇。综述确定了影响低胆固醇胆囊切除术结果的几个关键风险因素,包括与患者相关的因素,如高龄、高合并症评分、狭窄的胆管和复杂的结石,这些因素增加了并发症发生的可能性。外科医生的经验也起着至关重要的作用,据观察,10 年内至少实施过 70 例低密度胆囊切除术的外科医生的并发症发生率较低。此外,经膀胱 (TC) 方法、主要缝合 (PS) 闭合和术中成像等与手术相关的因素也能降低并发症发生率。LCBDE仍然是一种很有前景的胆管结石治疗方法,尤其是在患者、外科医生和手术因素都得到优化的情况下。
{"title":"Exploring Risk Factors for Post-operative Complications in Laparoscopic Common Bile Duct Exploration: A Literature Review.","authors":"Mina Manasseh, Islam Mt Elsamalouty, Cho Nu San, Marcos Kostalas","doi":"10.7759/cureus.72570","DOIUrl":"https://doi.org/10.7759/cureus.72570","url":null,"abstract":"<p><p>Gallstone-related diseases, particularly common bile duct (CBD) stones, pose a significant global health challenge. The emergence of laparoscopic common bile duct exploration (LCBDE) has transformed the management of these conditions by offering a less invasive alternative to traditional open surgery. This literature review aims to analyze published literature to identify and understand the risk factors associated with LCBDE. The study aims to offer valuable insights that could potentially enhance patient care and outcomes in managing CBD stones. A comprehensive search of English-language studies from the past 20 years was conducted using PubMed, focusing on peer-reviewed primary research, systematic reviews, and meta-analyses. From 830 initial articles, 25 were selected based on relevance and availability. The review identified several key risk factors influencing LCBDE outcomes, including patient-related factors such as advanced age, high comorbidity scores, narrow bile ducts, and complex stones, which increase the likelihood of complications. Surgeon experience also plays a crucial role, with lower complication rates observed among surgeons who have performed at least 70 LCBDE procedures over a 10-year period. Additionally, procedure-related factors such as the transcystic (TC) approach, primary suture (PS) closure, and intraoperative imaging were found to reduce complication rates. LCBDE remains a promising approach for managing bile duct stones, particularly when patient, surgeon, and procedural factors are optimized.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11519757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142549730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scalp Metastasis From Renal Cell Carcinoma: A Rare Case With Rapid Progression. 肾细胞癌头皮转移:进展迅速的罕见病例
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-28 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72546
Mohammed S Alzahrani, Abdulsamad O Alharbi, Abdulaziz Alghamdi, Abdulrahman Mojallid, Mohamed Alghamdi, Abdullrahman Alayyad, Awnallah Alotaibi, Abdulrhman A Alamri, Rehab Fadag, Mohamed Sheta, Abdulrahman S Khalil, Ibrahem F Alassiri, Abdulghani Khogeer, Adel Elatreisy

Renal cell carcinoma (RCC) is a common renal malignancy that frequently metastasizes, though cutaneous metastasis, particularly to the scalp, is rare and generally indicates a poor prognosis. We report a case of scalp metastasis from RCC in a 69-year-old man who presented with unexplained weight loss and painless hematuria. Imaging revealed a 12-cm renal mass with adrenal, pulmonary, and scalp metastases. The patient's condition rapidly deteriorated, and he died one month after the presentation. Hematogenous spread through Batson's plexus might be the primary mechanism of RCC dissemination to the scalp. While targeted therapies have improved the management of metastatic RCC, the prognosis for patients with skin metastases remains poor.

肾细胞癌(RCC)是一种常见的肾脏恶性肿瘤,经常发生转移,但皮肤转移,尤其是头皮转移并不多见,一般预后较差。我们报告了一例由 RCC 转移至头皮的病例,患者是一名 69 岁的男性,曾出现不明原因的体重减轻和无痛性血尿。影像学检查发现其肾脏肿块达 12 厘米,并伴有肾上腺、肺部和头皮转移。患者病情迅速恶化,在发病一个月后死亡。通过巴特森丛的血源性扩散可能是 RCC 向头皮扩散的主要机制。虽然靶向疗法改善了转移性 RCC 的治疗,但皮肤转移患者的预后仍然很差。
{"title":"Scalp Metastasis From Renal Cell Carcinoma: A Rare Case With Rapid Progression.","authors":"Mohammed S Alzahrani, Abdulsamad O Alharbi, Abdulaziz Alghamdi, Abdulrahman Mojallid, Mohamed Alghamdi, Abdullrahman Alayyad, Awnallah Alotaibi, Abdulrhman A Alamri, Rehab Fadag, Mohamed Sheta, Abdulrahman S Khalil, Ibrahem F Alassiri, Abdulghani Khogeer, Adel Elatreisy","doi":"10.7759/cureus.72546","DOIUrl":"10.7759/cureus.72546","url":null,"abstract":"<p><p>Renal cell carcinoma (RCC) is a common renal malignancy that frequently metastasizes, though cutaneous metastasis, particularly to the scalp, is rare and generally indicates a poor prognosis. We report a case of scalp metastasis from RCC in a 69-year-old man who presented with unexplained weight loss and painless hematuria. Imaging revealed a 12-cm renal mass with adrenal, pulmonary, and scalp metastases. The patient's condition rapidly deteriorated, and he died one month after the presentation. Hematogenous spread through Batson's plexus might be the primary mechanism of RCC dissemination to the scalp. While targeted therapies have improved the management of metastatic RCC, the prognosis for patients with skin metastases remains poor.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514952/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brachial Plexus Injury Following Fracture-Dislocation of the Proximal Humerus: A Case Report. 肱骨近端骨折-脱位后臂丛神经损伤:病例报告。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-28 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72593
Samuel J Smith, Andy Webb

Fracture-dislocations of the proximal humerus with brachial plexus injury are exceedingly rare, and although infrequently encountered, it is important to recognize this complication due to its potentially devastating impact. We present the case of a 75-year-old female who sustained the described injury following a fall onto their left arm, demonstrating combined sensory and motor deficits in the radial, median, and ulnar distribution of the left forearm and hand shortly afterward. Immediate management involved closed reduction under anesthesia, resulting in the improvement of neurological symptoms. For definitive management, surgical fixation of the fracture-dislocation is normally recommended in cases with an associated brachial plexus injury. However, due to a range of personal factors, the patient decided against this. Physiotherapy plays an important role in the management of these injuries, aiding mobility and recovery, with another key part of the follow-up being electrodiagnostic studies. These allow the physician to assess the extent of injury, monitor recovery for prognostication, and aid decisions regarding further surgical management. The importance of these studies is highlighted by the finding of severe brachial plexus injury, despite minimal pathological changes on MRI. Rare but significant, it is important to maintain a high index of suspicion for these injuries and consider underlying risk factors, with prompt surgical input required to optimize outcomes. Alongside surgical management, a considered approach must be taken by the anesthetic team, as regional anesthesia can confound post-procedure neurological assessment.

伴有臂丛神经损伤的肱骨近端骨折脱位极为罕见,尽管这种并发症并不常见,但由于其潜在的破坏性影响,认识这种并发症非常重要。我们介绍了一例 75 岁女性患者的病例,她在跌倒后左臂受到上述损伤,不久后左前臂和手部的桡侧、正中和尺侧分布出现合并感觉和运动障碍。立即采取的治疗措施包括在麻醉下进行闭合复位,从而改善了神经症状。对于伴有臂丛神经损伤的病例,通常建议采用外科手术固定骨折脱位。然而,由于一系列个人因素,患者决定不接受手术。物理治疗在这些损伤的治疗中发挥着重要作用,有助于活动和恢复,而后续治疗的另一个关键部分是电诊断研究。这些研究使医生能够评估损伤程度、监测恢复情况以确定预后,并帮助做出进一步手术治疗的决定。尽管核磁共振成像的病理变化极小,但如果发现臂丛神经损伤严重,这些检查就显得尤为重要。这些损伤虽然罕见,但意义重大,因此必须保持高度怀疑,并考虑潜在的风险因素,及时进行手术治疗,以优化预后。除手术治疗外,麻醉团队还必须采取深思熟虑的方法,因为区域麻醉可能会影响术后神经评估。
{"title":"Brachial Plexus Injury Following Fracture-Dislocation of the Proximal Humerus: A Case Report.","authors":"Samuel J Smith, Andy Webb","doi":"10.7759/cureus.72593","DOIUrl":"10.7759/cureus.72593","url":null,"abstract":"<p><p>Fracture-dislocations of the proximal humerus with brachial plexus injury are exceedingly rare, and although infrequently encountered, it is important to recognize this complication due to its potentially devastating impact. We present the case of a 75-year-old female who sustained the described injury following a fall onto their left arm, demonstrating combined sensory and motor deficits in the radial, median, and ulnar distribution of the left forearm and hand shortly afterward. Immediate management involved closed reduction under anesthesia, resulting in the improvement of neurological symptoms. For definitive management, surgical fixation of the fracture-dislocation is normally recommended in cases with an associated brachial plexus injury. However, due to a range of personal factors, the patient decided against this. Physiotherapy plays an important role in the management of these injuries, aiding mobility and recovery, with another key part of the follow-up being electrodiagnostic studies. These allow the physician to assess the extent of injury, monitor recovery for prognostication, and aid decisions regarding further surgical management. The importance of these studies is highlighted by the finding of severe brachial plexus injury, despite minimal pathological changes on MRI. Rare but significant, it is important to maintain a high index of suspicion for these injuries and consider underlying risk factors, with prompt surgical input required to optimize outcomes. Alongside surgical management, a considered approach must be taken by the anesthetic team, as regional anesthesia can confound post-procedure neurological assessment.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11526838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Intramedullary Nailing Versus Plate Fixation in the Management of Humeral Shaft Fractures: A Systematic Review and Meta-Analysis. 髓内钉与钢板固定治疗肱骨轴骨折的效果:系统回顾与元分析》。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-27 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72473
Adeel Nadeem, Hannah Abbasi

This systematic review and meta-analysis aimed to compare the outcomes of intramedullary nailing (IMN) and open reduction with internal fixation (ORIF) in treating traumatic humeral shaft fractures in adults (18 years and above). A comprehensive literature search was conducted in databases including PubMed, Google Scholar, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). The primary outcome was time to union, while secondary outcomes included non-union rates, incidences of iatrogenic radial nerve palsy, surgical site infections, and intra-operative comminution. Twenty-six studies, encompassing 1,674 patients (867 IMN, 807 ORIF), were included. IMN demonstrated a shorter time to union compared to ORIF (mean difference -1.06 (95% CI, -1.88 to -0.23)), with significant statistical heterogeneity (I² = 70%), and a mean difference of -2.14 (95% CI, -3.16 to -1.12) in the randomized controlled trial (RCT) subgroup analysis, which had no significant statistical heterogeneity. Both techniques had comparable non-union rates (risk ratio 0.34 (95% CI, 0.94 to 1.93)). IMN was associated with lower incidences of iatrogenic radial nerve palsy (risk ratio 0.48 (95% CI, 0.27 to 0.87)) and surgical site infections (risk ratio 0.44 (95% CI, 0.25 to 0.76)), but had a higher risk of intra-operative comminution (risk ratio 3.04 (95% CI, 1.24 to 7.44)). The studies exhibited significant heterogeneity and varying outcome measures, highlighting the need for cautious interpretation. IMN offers rapid fracture stabilization and minimal additional physiological insult, while ORIF remains preferable for achieving precise anatomical reduction. These findings highlight the importance of considering patient-specific factors and surgical expertise in selecting the appropriate fixation technique.

本系统综述和荟萃分析旨在比较髓内钉(IMN)和切开复位内固定(ORIF)治疗成人(18 岁及以上)创伤性肱骨轴骨折的疗效。我们在PubMed、Google Scholar、Embase和Cochrane对照试验中央注册中心(CENTRAL)等数据库中进行了全面的文献检索。研究的主要结果是骨折愈合时间,次要结果包括骨折不愈合率、先天性桡神经麻痹发生率、手术部位感染和术中粉碎。26项研究共纳入1674例患者(867例IMN,807例ORIF)。在随机对照试验(RCT)亚组分析中,两者的平均差异为-2.14(95% CI,-3.16至-1.12),无显著的统计学异质性。两种技术的不愈合率相当(风险比为 0.34(95% CI,0.94 至 1.93))。IMN 与先天性桡神经麻痹(风险比 0.48(95% CI,0.27 至 0.87))和手术部位感染(风险比 0.44(95% CI,0.25 至 0.76))的发生率较低相关,但术中粉碎的风险较高(风险比 3.04(95% CI,1.24 至 7.44))。这些研究显示出明显的异质性和不同的结果衡量标准,强调了谨慎解释的必要性。IMN能快速稳定骨折并将额外的生理损伤降至最低,而ORIF仍是实现精确解剖复位的首选。这些研究结果凸显了在选择合适的固定技术时考虑患者特异性因素和手术专业知识的重要性。
{"title":"Outcomes of Intramedullary Nailing Versus Plate Fixation in the Management of Humeral Shaft Fractures: A Systematic Review and Meta-Analysis.","authors":"Adeel Nadeem, Hannah Abbasi","doi":"10.7759/cureus.72473","DOIUrl":"10.7759/cureus.72473","url":null,"abstract":"<p><p>This systematic review and meta-analysis aimed to compare the outcomes of intramedullary nailing (IMN) and open reduction with internal fixation (ORIF) in treating traumatic humeral shaft fractures in adults (18 years and above). A comprehensive literature search was conducted in databases including PubMed, Google Scholar, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL). The primary outcome was time to union, while secondary outcomes included non-union rates, incidences of iatrogenic radial nerve palsy, surgical site infections, and intra-operative comminution. Twenty-six studies, encompassing 1,674 patients (867 IMN, 807 ORIF), were included. IMN demonstrated a shorter time to union compared to ORIF (mean difference -1.06 (95% CI, -1.88 to -0.23)), with significant statistical heterogeneity (I² = 70%), and a mean difference of -2.14 (95% CI, -3.16 to -1.12) in the randomized controlled trial (RCT) subgroup analysis, which had no significant statistical heterogeneity. Both techniques had comparable non-union rates (risk ratio 0.34 (95% CI, 0.94 to 1.93)). IMN was associated with lower incidences of iatrogenic radial nerve palsy (risk ratio 0.48 (95% CI, 0.27 to 0.87)) and surgical site infections (risk ratio 0.44 (95% CI, 0.25 to 0.76)), but had a higher risk of intra-operative comminution (risk ratio 3.04 (95% CI, 1.24 to 7.44)). The studies exhibited significant heterogeneity and varying outcome measures, highlighting the need for cautious interpretation. IMN offers rapid fracture stabilization and minimal additional physiological insult, while ORIF remains preferable for achieving precise anatomical reduction. These findings highlight the importance of considering patient-specific factors and surgical expertise in selecting the appropriate fixation technique.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514719/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Epoetin Alfa in Managing Symptomatic Anaemia in Low-Risk Myelodysplastic Syndromes: A Retrospective Analysis. Epoetin Alfa 在治疗低风险骨髓增生异常综合征症状性贫血中的疗效:回顾性分析
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-27 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72460
Mohamed Aboulela, Angela Collins

Background Myelodysplastic syndromes (MDS) are clonal myeloid disorders characterised by ineffective haematopoiesis, leading to anaemia that often requires dependence on red blood cell (RBC) transfusions. Epoetin alfa (Eprex®) is now a mainstay in the management of symptomatic anaemia in low-risk MDS patients, reducing transfusion dependence and improving the quality of life in this patient group. Objective This retrospective study aimed to assess the efficacy of epoetin alfa in treating symptomatic anaemia in low-risk MDS patients, focusing on transfusion independence and its relationship with baseline erythropoietin (EPO) levels and haemoglobin (Hb) response. Methods Data from 56 patients with low-risk MDS treated with epoetin alfa at Norfolk and Norwich University Hospital, Norwich, United Kingdom, between 2018 and 2023 were retrospectively analysed. Baseline EPO levels, transfusion history, Hb response, and the duration of transfusion independence were assessed. Statistical analyses were performed to evaluate the correlation between baseline characteristics and treatment outcomes. Results Among the patients, 98.2% had baseline EPO levels below the 500 IU/L threshold, with a median EPO level of 74.3 IU/L. Following an eight-week trial of 30,000 units of epoetin-alfa, 41.1% of patients showed improved Hb levels, 41.1% maintained stable Hb levels, and 17.9% experienced a decline. A significant correlation was found between lower baseline EPO levels (<250 IU/L) and a positive treatment response (p = 0.0065). Additionally, patients who required fewer transfusions before treatment had longer durations of transfusion independence (correlation coefficient = -0.40, p = 0.015). Dose escalation to 60,000 units provided a benefit to 53.3% of patients with initially stable Hb levels. The average duration of transfusion independence was 8.1 months, and patients with improved Hb levels had the longest periods of transfusion independence (p = 0.005). Conclusion Epoetin alfa is an effective therapy for managing symptomatic anaemia in low-risk MDS patients. This study highlights its efficacy and provides valuable predictive information, particularly showing that patients with lower baseline EPO levels are more likely to respond to treatment. While prior transfusion dependence did not significantly predict response to therapy in this cohort, it was associated with the duration of transfusion independence.

背景 骨髓增生异常综合征(MDS)是一种克隆性骨髓疾病,其特点是造血功能低下,导致贫血,常常需要依赖输注红细胞(RBC)。目前,Epoetin alfa(Eprex®)已成为治疗低危 MDS 患者症状性贫血的主要药物,可减少对输血的依赖性,提高这类患者的生活质量。目的 本回顾性研究旨在评估epoetin alfa治疗低危MDS患者症状性贫血的疗效,重点关注输血独立性及其与基线促红细胞生成素(EPO)水平和血红蛋白(Hb)反应的关系。方法 回顾性分析了英国诺福克和诺里奇大学医院在2018年至2023年期间用环氧乙烷α治疗的56名低风险MDS患者的数据。评估了基线 EPO 水平、输血史、Hb 反应和输血独立性持续时间。进行了统计分析,以评估基线特征与治疗结果之间的相关性。结果 98.2% 的患者 EPO 水平低于 500 IU/L 临界值,EPO 水平中位数为 74.3 IU/L。在接受为期八周的 30,000 单位环孢素-阿法治疗后,41.1% 的患者血红蛋白水平有所改善,41.1% 的患者血红蛋白水平保持稳定,17.9% 的患者血红蛋白水平有所下降。研究发现,较低的基线 EPO 含量与 Hb 含量之间存在明显的相关性 (
{"title":"Efficacy of Epoetin Alfa in Managing Symptomatic Anaemia in Low-Risk Myelodysplastic Syndromes: A Retrospective Analysis.","authors":"Mohamed Aboulela, Angela Collins","doi":"10.7759/cureus.72460","DOIUrl":"10.7759/cureus.72460","url":null,"abstract":"<p><p>Background Myelodysplastic syndromes (MDS) are clonal myeloid disorders characterised by ineffective haematopoiesis, leading to anaemia that often requires dependence on red blood cell (RBC) transfusions. Epoetin alfa (Eprex®) is now a mainstay in the management of symptomatic anaemia in low-risk MDS patients, reducing transfusion dependence and improving the quality of life in this patient group. Objective This retrospective study aimed to assess the efficacy of epoetin alfa in treating symptomatic anaemia in low-risk MDS patients, focusing on transfusion independence and its relationship with baseline erythropoietin (EPO) levels and haemoglobin (Hb) response. Methods Data from 56 patients with low-risk MDS treated with epoetin alfa at Norfolk and Norwich University Hospital, Norwich, United Kingdom, between 2018 and 2023 were retrospectively analysed. Baseline EPO levels, transfusion history, Hb response, and the duration of transfusion independence were assessed. Statistical analyses were performed to evaluate the correlation between baseline characteristics and treatment outcomes. Results Among the patients, 98.2% had baseline EPO levels below the 500 IU/L threshold, with a median EPO level of 74.3 IU/L. Following an eight-week trial of 30,000 units of epoetin-alfa, 41.1% of patients showed improved Hb levels, 41.1% maintained stable Hb levels, and 17.9% experienced a decline. A significant correlation was found between lower baseline EPO levels (<250 IU/L) and a positive treatment response (p = 0.0065). Additionally, patients who required fewer transfusions before treatment had longer durations of transfusion independence (correlation coefficient = -0.40, p = 0.015). Dose escalation to 60,000 units provided a benefit to 53.3% of patients with initially stable Hb levels. The average duration of transfusion independence was 8.1 months, and patients with improved Hb levels had the longest periods of transfusion independence (p = 0.005). Conclusion Epoetin alfa is an effective therapy for managing symptomatic anaemia in low-risk MDS patients. This study highlights its efficacy and provides valuable predictive information, particularly showing that patients with lower baseline EPO levels are more likely to respond to treatment. While prior transfusion dependence did not significantly predict response to therapy in this cohort, it was associated with the duration of transfusion independence.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512730/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alginate Use in Orthopedics and Peripheral Nerve Repair: A Systematic Review. 藻酸盐在矫形外科和周围神经修复中的应用:系统综述。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-27 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72480
Matthew T Eisenberg, Joshua W Hustedt

The use of alginate, a derivative of seaweed, has been proposed for multiple orthopedic indications. We aimed to review the current use of alginate in orthopedics and to focus on the future applications of alginate for peripheral nerve repair. A comprehensive literature search was performed to identify biomechanical, laboratory, animal, and human studies where alginate has been utilized for orthopedic or nerve repair indications. A systematic review of orthopedic indications was conducted for safety and efficacy, and a specific focus was placed on alginate for use in peripheral nerve repair and reconstruction. Thirty-two studies were identified. Alginate has a strong history and safety profile for usage in orthopedic surgery. Its primary usage has been for the repair of articular cartilage, although it has also been used for disc regeneration of the lumbar spine and for cushioning joints in osteoarthritis. The primary indication in peripheral nerve repair is to create an environment that encourages Schwann cell migration and repair in nerve injuries while blocking fibrotic scar tissue formation by inhibiting the activity of fibroblasts. Alginate hydrogel may serve as a potential conduit for nerve regeneration in nerve injuries with small to medium-sized gaps.

海藻酸盐是海藻的一种衍生物,已被提议用于多种骨科适应症。我们旨在回顾海藻酸盐目前在骨科中的应用,并重点关注海藻酸盐未来在周围神经修复中的应用。我们进行了全面的文献检索,以确定将海藻酸盐用于骨科或神经修复适应症的生物力学、实验室、动物和人体研究。对骨科适应症的安全性和有效性进行了系统回顾,并特别关注了用于周围神经修复和重建的海藻酸盐。共确定了 32 项研究。藻酸盐在骨科手术中的应用历史悠久,安全性高。其主要用途是修复关节软骨,但也用于腰椎间盘再生和骨关节炎的关节缓冲。周围神经修复的主要用途是创造一种环境,促进许旺细胞的迁移和神经损伤的修复,同时通过抑制成纤维细胞的活性阻止纤维化瘢痕组织的形成。藻酸盐水凝胶可作为一种潜在的管道,用于具有中小型间隙的神经损伤的神经再生。
{"title":"Alginate Use in Orthopedics and Peripheral Nerve Repair: A Systematic Review.","authors":"Matthew T Eisenberg, Joshua W Hustedt","doi":"10.7759/cureus.72480","DOIUrl":"10.7759/cureus.72480","url":null,"abstract":"<p><p>The use of alginate, a derivative of seaweed, has been proposed for multiple orthopedic indications. We aimed to review the current use of alginate in orthopedics and to focus on the future applications of alginate for peripheral nerve repair. A comprehensive literature search was performed to identify biomechanical, laboratory, animal, and human studies where alginate has been utilized for orthopedic or nerve repair indications. A systematic review of orthopedic indications was conducted for safety and efficacy, and a specific focus was placed on alginate for use in peripheral nerve repair and reconstruction. Thirty-two studies were identified. Alginate has a strong history and safety profile for usage in orthopedic surgery. Its primary usage has been for the repair of articular cartilage, although it has also been used for disc regeneration of the lumbar spine and for cushioning joints in osteoarthritis. The primary indication in peripheral nerve repair is to create an environment that encourages Schwann cell migration and repair in nerve injuries while blocking fibrotic scar tissue formation by inhibiting the activity of fibroblasts. Alginate hydrogel may serve as a potential conduit for nerve regeneration in nerve injuries with small to medium-sized gaps.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536484/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142585218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal Endothelial Graft Failure After Endoscopic Cyclophotocoagulation: A Case Report. 内窥镜环形光凝术后角膜内皮移植失败:病例报告。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-26 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72407
Katsuhiko Maruyama, Masaki Tanito, Takefumi Yamaguchi, Jun Shimazaki

We report a case of corneal endothelial graft failure that developed after endoscopic cyclophotocoagulation (ECP) for elevated intraocular pressure (IOP) following Descemet's stripping automated endothelial keratoplasty (DSAEK). The patient was a 69-year-old Japanese woman with primary angle-closure glaucoma who had undergone phacoemulsification with intraocular lens implantation and goniosynechialysis for peripheral anterior synechiae (PAS), followed by trabeculectomy, repeat bleb revisions, Baerveldt glaucoma implant surgery, and Ahmed glaucoma valve implantation with tube insertion into the anterior chamber in the past two years. Subsequently, she developed bullous keratopathy, and the first DSAEK was performed in July 2020. Subsequently, iris adhesion and atrophy progressed around the tube, and PAS became severe, resulting in graft failure. A second DSAEK combined with pupilloplasty was performed in November 2021, after which the graft transparency was maintained. Since March 2022, IOP has increased despite treatment with maximum medication; therefore, ECP was performed to reduce IOP in September 2022. IOP decreased after ECP; however, the patient developed graft failure within a few months. A third DSAEK was performed in July 2023. In conclusion, for eyes with borderline corneal endothelial cell decompensation, the indications for ECP should be decided with caution.

我们报告了一例角膜内皮移植失败的病例,该病例是在进行内窥镜环形光凝术(ECP)治疗眼内压(IOP)升高后,进行了去角膜剥离自动内皮角膜移植术(DSAEK)。患者是一名 69 岁的日本女性,患有原发性闭角型青光眼,在过去两年中接受了周边前房裂伤(PAS)的超声乳化术、眼内晶体植入术和巩膜切开术,之后又接受了小梁切除术、重复眼裂修整术、Baerveldt 青光眼植入手术和 Ahmed 青光眼瓣膜植入术,并将导管插入前房。随后,她患上了牛皮状角膜病,并于 2020 年 7 月进行了第一次 DSAEK 手术。随后,虹膜粘连和萎缩在导管周围发展,PAS变得严重,导致移植失败。2021 年 11 月进行了第二次 DSAEK 联合瞳孔成形术,术后移植物的透明度得以维持。自 2022 年 3 月起,尽管使用了最大限度的药物治疗,但眼压仍在上升;因此,2022 年 9 月进行了 ECP 以降低眼压。ECP 后,眼压有所下降;但几个月后,患者出现移植物失效。2023 年 7 月,进行了第三次 DSAEK。总之,对于边缘性角膜内皮细胞失代偿的眼睛,应谨慎决定 ECP 的适应症。
{"title":"Corneal Endothelial Graft Failure After Endoscopic Cyclophotocoagulation: A Case Report.","authors":"Katsuhiko Maruyama, Masaki Tanito, Takefumi Yamaguchi, Jun Shimazaki","doi":"10.7759/cureus.72407","DOIUrl":"10.7759/cureus.72407","url":null,"abstract":"<p><p>We report a case of corneal endothelial graft failure that developed after endoscopic cyclophotocoagulation (ECP) for elevated intraocular pressure (IOP) following Descemet's stripping automated endothelial keratoplasty (DSAEK). The patient was a 69-year-old Japanese woman with primary angle-closure glaucoma who had undergone phacoemulsification with intraocular lens implantation and goniosynechialysis for peripheral anterior synechiae (PAS), followed by trabeculectomy, repeat bleb revisions, Baerveldt glaucoma implant surgery, and Ahmed glaucoma valve implantation with tube insertion into the anterior chamber in the past two years. Subsequently, she developed bullous keratopathy, and the first DSAEK was performed in July 2020. Subsequently, iris adhesion and atrophy progressed around the tube, and PAS became severe, resulting in graft failure. A second DSAEK combined with pupilloplasty was performed in November 2021, after which the graft transparency was maintained. Since March 2022, IOP has increased despite treatment with maximum medication; therefore, ECP was performed to reduce IOP in September 2022. IOP decreased after ECP; however, the patient developed graft failure within a few months. A third DSAEK was performed in July 2023. In conclusion, for eyes with borderline corneal endothelial cell decompensation, the indications for ECP should be decided with caution.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11513220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142523895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pregnancy Complicated by Extrahepatic Portal Vein Occlusion and Portal Vein Thrombosis: A Case Report. 妊娠并发肝外门静脉闭塞和门静脉血栓:病例报告。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-26 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72457
Shingo Hosomi, Rie Oyama, Chizuko Isurugi, Takanori Sato, Tsukasa Baba

We report the case of a 38-year-old woman with a history of extrahepatic portal vein obstruction (EHPVO) who became pregnant and developed portal vein thrombosis. She gave birth after intervention by gastroenterology and cardiology. She was referred to our department due to significant leg edema at eight weeks of gestation, and we noticed EHPVO, portal vein thrombosis, and left pulmonary arteriovenous fistula by contrast-enhanced CT. Therefore, subcutaneous heparin injections of 10,000 units/day were started as a preventive anticoagulant therapy. We performed an emergency cesarean section at 36 weeks of gestation. After surgery, the mother was administered a continuous heparin infusion. On the 11th day after surgery, the postoperative progress was good, so heparin was switched to oral warfarin, and the patient was discharged on the same day. During pregnancy, the risk of varicose vein rupture, hyperammonemia, and pulmonary hypertension increases due to an increase in circulating blood volume. This was a case in which careful perinatal management was performed in collaboration with other departments, resulting in a live birth.

我们报告了这样一例病例:一名有肝外门静脉阻塞(EHPVO)病史的 38 岁女性怀孕后出现了门静脉血栓。在消化内科和心脏内科的干预下,她顺利分娩。她在妊娠八周时因腿部明显水肿转诊至我科,我们通过对比增强 CT 发现她患有肝外门静脉阻塞(EHPVO)、门静脉血栓和左肺动静脉瘘。因此,我们开始皮下注射肝素 10,000 单位/天,作为预防性抗凝治疗。我们在妊娠 36 周时进行了紧急剖宫产手术。术后,为产妇持续输注肝素。术后第 11 天,术后进展良好,因此将肝素改为口服华法林,患者于当天出院。妊娠期间,由于循环血量增加,静脉曲张破裂、高氨血症和肺动脉高压的风险也会增加。在这一病例中,医生与其他科室合作进行了精心的围产期管理,最终使患者顺利产下一子。
{"title":"Pregnancy Complicated by Extrahepatic Portal Vein Occlusion and Portal Vein Thrombosis: A Case Report.","authors":"Shingo Hosomi, Rie Oyama, Chizuko Isurugi, Takanori Sato, Tsukasa Baba","doi":"10.7759/cureus.72457","DOIUrl":"10.7759/cureus.72457","url":null,"abstract":"<p><p>We report the case of a 38-year-old woman with a history of extrahepatic portal vein obstruction (EHPVO) who became pregnant and developed portal vein thrombosis. She gave birth after intervention by gastroenterology and cardiology. She was referred to our department due to significant leg edema at eight weeks of gestation, and we noticed EHPVO, portal vein thrombosis, and left pulmonary arteriovenous fistula by contrast-enhanced CT. Therefore, subcutaneous heparin injections of 10,000 units/day were started as a preventive anticoagulant therapy. We performed an emergency cesarean section at 36 weeks of gestation. After surgery, the mother was administered a continuous heparin infusion. On the 11th day after surgery, the postoperative progress was good, so heparin was switched to oral warfarin, and the patient was discharged on the same day. During pregnancy, the risk of varicose vein rupture, hyperammonemia, and pulmonary hypertension increases due to an increase in circulating blood volume. This was a case in which careful perinatal management was performed in collaboration with other departments, resulting in a live birth.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142516835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Intermittent Porphyria: A Diagnostic Conundrum. 急性间歇性卟啉症:诊断难题。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-26 eCollection Date: 2024-10-01 DOI: 10.7759/cureus.72419
Vijay Balaji Vadivel, Simran Lamba

This case report presents the case of a 20-year-old female patient who sought emergency medical attention for severe abdominal pain, nausea and vomiting, tachycardia, hypertension, and discolored urine. Initial diagnostic evaluations yielded no significant abnormalities; however, subsequent analysis revealed elevated urinary porphobilinogen, corroborating a diagnosis of acute intermittent porphyria (AIP). The patient's medical history included recurrent urinary tract infections and a prior episode of syndrome of inappropriate antidiuretic hormone secretion (SIADH), in conjunction with psychiatric comorbidities of anxiety and depression. Management encompassed a multifaceted approach involving supportive therapies, such as hydration and analgesia, alongside the imperative to abstain from using contraindicated pharmacological agents. Following referral to the National Acute Porphyria Service (NAPS), the patient received intravenous Haem arginate, resulting in clinical improvement and subsequent discharge. Nonetheless, she later necessitated further hospitalization due to the recurrence of similar symptoms. This case highlights the exigency of recognizing AIP in young women presenting with nonspecific symptoms, necessitating a high index of clinical suspicion. Furthermore, it accentuates the critical importance of early specialist intervention to avert severe sequelae associated with acute episodes. The integration of targeted educational initiatives within Acute Medicine departments is paramount for fostering awareness and facilitating prompt diagnosis and management of this rare yet significant disorder.

本病例报告介绍了一名 20 岁女性患者的病例,她因剧烈腹痛、恶心呕吐、心动过速、高血压和尿液变色而急诊就医。初步诊断评估未发现明显异常,但随后的分析显示尿卟啉原升高,证实了急性间歇性卟啉症(AIP)的诊断。该患者的病史包括反复尿路感染、抗利尿激素分泌失调综合征(SIADH)以及焦虑和抑郁等精神并发症。治疗包括多方面的方法,包括水合和镇痛等支持性疗法,同时必须避免使用禁忌的药物。在转诊至国家急性卟啉症服务机构(NAPS)后,患者接受了精氨酸血红蛋白静脉注射,临床症状有所改善,随后出院。然而,由于类似症状再次出现,她不得不再次住院治疗。本病例突出表明,对于出现非特异性症状的年轻女性,必须高度怀疑其是否患有 AIP。此外,它还强调了早期专科干预对避免急性发作相关严重后遗症的极端重要性。在急诊医学科内开展有针对性的教育活动,对于提高人们对这一罕见而重要疾病的认识、促进及时诊断和管理至关重要。
{"title":"Acute Intermittent Porphyria: A Diagnostic Conundrum.","authors":"Vijay Balaji Vadivel, Simran Lamba","doi":"10.7759/cureus.72419","DOIUrl":"10.7759/cureus.72419","url":null,"abstract":"<p><p>This case report presents the case of a 20-year-old female patient who sought emergency medical attention for severe abdominal pain, nausea and vomiting, tachycardia, hypertension, and discolored urine. Initial diagnostic evaluations yielded no significant abnormalities; however, subsequent analysis revealed elevated urinary porphobilinogen, corroborating a diagnosis of acute intermittent porphyria (AIP). The patient's medical history included recurrent urinary tract infections and a prior episode of syndrome of inappropriate antidiuretic hormone secretion (SIADH), in conjunction with psychiatric comorbidities of anxiety and depression. Management encompassed a multifaceted approach involving supportive therapies, such as hydration and analgesia, alongside the imperative to abstain from using contraindicated pharmacological agents. Following referral to the National Acute Porphyria Service (NAPS), the patient received intravenous Haem arginate, resulting in clinical improvement and subsequent discharge. Nonetheless, she later necessitated further hospitalization due to the recurrence of similar symptoms. This case highlights the exigency of recognizing AIP in young women presenting with nonspecific symptoms, necessitating a high index of clinical suspicion. Furthermore, it accentuates the critical importance of early specialist intervention to avert severe sequelae associated with acute episodes. The integration of targeted educational initiatives within Acute Medicine departments is paramount for fostering awareness and facilitating prompt diagnosis and management of this rare yet significant disorder.</p>","PeriodicalId":93960,"journal":{"name":"Cureus","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142515161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cureus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1